27.7 C
Vientiane
Wednesday, July 9, 2025
spot_img
Home Blog Page 100

UBTS and Cuber AI Launch Exploratory Study into Next-Gen Agentic AI for Logistics Innovation

Joint initiative to evaluate Agentic AI-driven transformation of supply chain operations across ASEAN

SINGAPORE, May 30, 2025 /PRNewswire/ — UBTS Pte Ltd, a leading Singapore homegrown logistics player, has embarked on an exploratory partnership with Cuber AI, a pioneer in agentic AI systems, to jointly assess the impact of advanced artificial intelligence on optimising supply chain and logistics operations. The study reflects both organisations’ shared vision of shaping the future of intelligent logistics across the region’s dynamic $2.9 trillion market.

Scope of the Study
The collaboration will involve a focused evaluation of Cuber AI’s autonomous decision-making platform in key areas such as:

  • Predictive Demand Forecasting – Using Agentic AI to analyze regional trade flow and forecast demand shifts
  • Dynamic Risk Mitigation – Enhancing response capabilities to route disruptions in real time
  • Intelligent Resource Allocation – Optimizing fleet and asset deployment through machine learning
  • Regulatory Compliance Automation – Streamlining cross-border logistics documentation with Agentic AI

“We view this as a collaborative exploration of what Agentic AI can enable in logistics—not just in terms of efficiency, but in rethinking supply chain adaptability itself,” said Mr. Jimmy Ng, UBTS Chairman. “Working with Cuber AI allows us to study innovative capabilities that could shape our next phase of growth.”

Strategic Outlook
This initiative complements UBTS’ ongoing digital transformation efforts, with key evaluation areas including:

  • Operational Agility – Potential to reduce crisis-response decision time by up to 60%
  • Sustainability Goals – Assessing Agentic AI’s ability to reduce emissions through smarter routing
  • Talent Evolution – Exploring hybrid workforce models that integrate human expertise and Agentic AI-driven support

“Our collaboration with UBTS is about jointly discovering what’s possible,” said [Mr. Ng Chee Keong Cuber AI Managing Director]. “This study will lay the foundation for cognitive supply chains that learn, adapt, and evolve in sync with market realities.”

About UBTS Group

Established in the 1960s, UBTS began operations in Singapore as a fledgling transportation company with only a dozen staff and several trucks. The 1980s saw the commencement of our warehousing, distribution and logistics services where we also began manufacturing 20-45 foot trailers. Since then, we have grown significantly to a staff size of 300 and a fleet of over 1000 vehicles, always making sure never to lose sight of our customers’ current and future needs.

About Cuber AI

Cuber AI, founded in 2024, is a global leader in digital employee robotics and AI hyperautomation. Headquartered in Singapore, with a growing presence across Asia, Cuber AI specializes in transforming the supply chain sector, encompassing manufacturing, logistics, and new retail, through state-of-the-art solutions powered by AI, digital robotics, and big data mining.

Teddy Laboratory (GuanHe Pharmaceuticals) Signs Strategic Cooperation Agreement with LabConnect to Forge a New Landscape in Laboratory Services Collaboration

JOHNSON CITY, Tenn., May 30, 2025 /PRNewswire/ — Teddy Laboratory, a subsidiary of Tigermed, officially signed a strategic cooperation agreement with LabConnect, LLC, a global leader in central laboratory services. The two parties will jointly build a full-chain laboratory service system covering both China and international markets to accelerate the development and commercialization of innovative drugs worldwide.

With this agreement, Teddy Laboratory will become LabConnect’s preferred laboratory partner in China, providing lab services that meet international regulatory standards and supporting multinational pharmaceutical companies conducting clinical trials in China. Meanwhile, LabConnect will become Teddy Lab’s preferred central lab partner for overseas operations, leveraging its extensive presence in key markets such as North America and Europe to help Chinese pharmaceutical companies expand globally.

Teddy Laboratory and LabConnect will establish a long-term preferred partnership, forming a complementary model of “China-based capabilities + global service network.”  “By fully leveraging our respective resources and technological strengths, we aim to further enhance global clinical trial service standards,” said Jeff Mayhew Chief Development Officer of LabConnect.

At the signing ceremony, Ms. Xu Yi, Chairwoman of Teddy Laboratory/GuanHe Pharmaceuticals, stated “LabConnect’s unique business model aligns well with Teddy’s localized strengths. Since our first Phase III clinical project together in 2022, we have successfully completed multiple international clinical trial collaborations.”

This strategic partnership marks not only a key milestone in Teddy Laboratories global expansion but also a deep integration of domestic and international central lab resources. In the future, both parties will continue working together to enhance global clinical trial service capabilities, support the development and launch of innovative drugs worldwide, and bring more advanced treatment options to patients.

About LabConnect

LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs. Learn more at www.labconnect.com and follow on LinkedIn.

About Teddy Laboratory/GuanHe Pharmaceuticals

Shanghai GuanHe Pharmaceutical Technology Co., Ltd., established in 2016, is a leading innovative and integrated lab service platform in the clinical research industry. With branches in Shanghai, Wuxi, Hangzhou, and Hong Kong, the company has built a one-stop service capability in central laboratory and bioanalysis, becoming an important player in full-chain clinical trial services. Teddy is a subsidiary controlled by Tigermed (300347.SZ / 3347.HK).

Teddy provides laboratory and scientific solutions to innovative drug companies to accelerate drug development and regulatory submissions. Its services span from biomarker discovery, target validation, patient enrichment, PK/PD studies, safety evaluation, to efficacy assessment and sample analysis. Teddy is committed to supporting clinical drug development with cutting-edge lab technologies. As of March 2025, Teddy has supported the approval of 37 new drugs and therapeutic products by China’s NMPA.

 

/C O R R E C T I O N — OHI Group S.A./

LUXEMBOURG, May 30, 2025 /PRNewswire/ — OHI Group S.A., a société anonyme organized under laws of Luxembourg (the “Issuer”), today announced that it intends to confidentially submit a draft registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its ordinary shares in the United States.

The timing, number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined. The proposed initial public offering is subject to market and other conditions, including completion of the SEC’s review of the registration statement.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). This announcement is being issued in accordance with Rule 135 under the Securities Act.

Contact:
Ivan Coyard
Group CFO
Phone: (+351) 910019317
e-mail: ivan.coyard@ohi.pt 

 

/C O R R E C T I O N — OHI Group S.A./

In the news release, OHI Group S.A. Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering, issued 29-May-2025 by OHI Group S.A. over PR Newswire, we are advised by the company of an update to the media contact. The complete, corrected release follows:

OHI Group S.A. Announces Intention to Submit Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

LUXEMBOURG, May 30, 2025 /PRNewswire/ — OHI Group S.A., a société anonyme organized under laws of Luxembourg (the “Issuer”), today announced that it intends to confidentially submit a draft registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its ordinary shares in the United States.

The timing, number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined. The proposed initial public offering is subject to market and other conditions, including completion of the SEC’s review of the registration statement.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). This announcement is being issued in accordance with Rule 135 under the Securities Act.

Contact:
Ivan Coyard
Group CFO
Phone: (+351) 910019317
e-mail: ivan.coyard@ohi.pt 

 

Concord Healthcare Announces Official Release of the Proton Therapy Large Model

BEIJING, May 30, 2025 /PRNewswire/ — Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 2453.HK, announced that Concord Healthcare had made important progress in precise tumor diagnosis and treatment technology. Concord Healthcare’s self-developed large language model (“LLM”) in the vertical field of proton therapy was officially released and successfully deployed in Guangzhou Concord Cancer Hospital. Since the commencement of the proton therapy in Guangzhou Concord Cancer Hospital, the proton therapy has completed a number of high-quality patient treatment cases, demonstrating the outstanding advantages of precise treatment, significant efficacy, and reduced side effects.

Concord Healthcare’s proton LLM is the first LLM focusing on proton therapy in China, and its research and development relies on the tumor diagnosis and treatment technology system and massive data accumulated by Concord Healthcare over the years. It integrates nearly 10,000 high-quality radiotherapy cases to construct multimodal medical data, and also integrates data from Proton China and professional journal literature to achieve enhancement of model training.

The Company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. The information related to Concord Healthcare’s Transactions on the HKSE is accessible through the HKSE’s website at www.hkexnews.hk.

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information, please see http://ir.ccm.cn.

About Concord Healthcare

Concord Healthcare is an oncology healthcare provider in China. Concord Healthcare serves both cancer patients through self-owned medical institutions and third-party medical institutions through medical equipment, software and related services. In its self-owned medical institutions, Concord Healthcare provides a full spectrum of oncology healthcare services to cancer patients across the entire care continuum, leveraging its multidisciplinary team specialists and diagnosis and treatment capabilities featuring precision radiation therapy. Through its medical equipment, software and related services, Concord Healthcare serves a widespread network of enterprise customers, primarily hospitals, with integrated oncology-related services, including primarily sales and installing of medical equipment and software, management and technical support, and operating lease.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company’s control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

 

New CE Summit Focuses on Veterinary Neurosurgery, Innovation, and Collaboration

BOZEMAN, Mont., May 30, 2025 /PRNewswire/ — Bridger Veterinary Specialists (BVS) proudly announces the inaugural BVS Neurosurgery Summit — a premier, two-and-a-half-day event focused on advancing the field of veterinary neurosurgery. Tailored for specialists and residents within ACVIM (Neurology), ECVN, ACVS, and ECVS, the summit will provide cutting-edge education, collaboration, and hands-on experience. 

Canine Vertebral Stabilization
Canine Vertebral Stabilization

The summit will take place September 19–21, 2025, at the Kimpton Armory Hotel in beautiful Bozeman, Montana. An optional hands-on dry lab will also be offered on September 22 at the BVS hospital.

This summit provides a unique opportunity for veterinary neurologists, surgeons, house officers, and students to engage in collaborative learning and professional development.

Event Highlights  

Expert-Led Sessions: Attendees will gain up to 14 hours of RACE-pending Continuing Education (CE) through case-based insights, research-driven lectures, expert-led discussions, and a half-day dry lab

Specialist-Level Lectures & Roundtables: Topics include intracranial surgery, skull reconstruction, minimally invasive neurosurgical techniques, spinal biomechanics, implant decision-making, comparative neurosurgery strategies, and advances in lumbosacral surgery.

Networking Opportunities: The summit fosters collaboration among peers and thought leaders in a picturesque mountain setting conducive to learning and recharging. 

Summit Registration Details

  • Residency-Trained Specialists:
  • $400 early bird pricing until July 1 – $500 thereafter
  • House Officers & Students: Complimentary
  • Meals: Complimentary breakfast and lunch provided

Dry Lab Registration Details:

  • $250 per attendee — space is limited.

For more information and to register, please visit the official summit website: https://bvspets.vet/neuro-summit 

Media Contact:
Marketing Director
marketing@bvspets.com
406-920-0160

 

VEX Robotics and RECF Partner with Saudi Federation to Enhance STEM Education in Saudi Arabia

Advancing STEM Learning with Innovative Robotics and Global Competition Access

RIYADH, Saudi Arabia, May 30, 2025 /PRNewswire/ — VEX Robotics, a global leader in educational robotics, and the Robotics Education & Competition Foundation (RECF) have announced an exciting partnership with the Saudi Federation of Robotics and RC Sports. This collaboration aims to significantly advance STEM (Science, Technology, Engineering, and Mathematics) education across Saudi Arabia by integrating cutting-edge robotics technology into classrooms and competitions.

This strategic partnership represents an important step in equipping Saudi students with world-class educational tools and platforms, aligning with the Kingdom’s technological innovation and youth empowerment vision. By fostering a culture of STEM excellence, this initiative will open new pathways for students to explore robotics, develop critical skills, and engage in global robotics competitions.

“We are thrilled to partner with the Saudi Federation of Robotics and RC Sports to bring the transformative power of robotics to students across Saudi Arabia,” said Tony Norman, CEO and founder of VEX Robotics. “This collaboration is about inspiring the next generation of innovators and problem-solvers by providing them with the tools they need to succeed in a rapidly evolving world.”

VEX Robotics offers a hands-on robotics education solution called the VEX Continuum, designed to engage students from elementary through university levels. The RECF organizes the world’s largest global robotics competition, encouraging students to apply classroom learning, develop hands-on problem-solving skills, and collaborate with peers in dynamic environments.

“We are honored to partner with VEX Robotics and RECF to enhance the robotics landscape in Saudi Arabia,” said Abdullah Alsunaydi, CEO of the Saudi Federation of Robotics and RC Sports. “This partnership supports our mission to cultivate a knowledge-driven society, nurture innovation, and create new opportunities for our youth.”

The collaboration will focus on expanding access to robotics education by providing teacher training and resources and establishing local, regional, and national competitions. These initiatives inspire students to explore STEM and build confidence in science, technology, and engineering careers.

Looking ahead, VEX Robotics, RECF, and the Saudi Federation aim to establish a sustainable ecosystem for robotics education in Saudi Arabia. Through this partnership, students will gain opportunities to compete on the global stage, representing Saudi Arabia in international competitions.

For more information on this groundbreaking initiative or to access exclusive resources from VEX Robotics and RECF, visit vexrobotics.com or recf.org

About VEX Robotics: VEX Robotics is a leading global educational and competition robotics solution provider. With a mission to inspire through hands-on learning, VEX offers a complete ecosystem of robotics hardware and software designed for engagement from elementary through university levels.

About Robotics Education & Competition Foundation: The RECF seeks to increase student interest in STEM by providing accessible robotics-based programs. It manages the world’s largest robotics competition, the VEX Robotics World Championship, inspiring critical skills development through hands-on experiences.

About the Saudi Federation of Robotics and RC Sports: The Federation promotes technological education within Saudi Arabia through programs encouraging youth participation in robotics that align with the nation’s vision for an innovative society.

VEX Robotics Media Contact
Madeleine Martin
FINN Partners
madeleine.martin@finnpartners.com
224.436.5267

REC Foundation Media Contact
Jenn Goonan
Rocket Social Impact
jenn@rocketsocialimpact.com
617.947.0971

The Saudi Federation for Robotics & RC Sports
The Saudi Federation for Robotics & RC Sports

 

Saudi Arabia at VEX Worlds
Saudi Arabia at VEX Worlds

 

Databricks Grows Operations in Costa Rica with New Office Expansion, Deepens Investment in Latin America

HEREDIA, Costa Rica, May 30, 2025 /PRNewswire/ — Databricks, the Data and AI company, today celebrated the opening of its new office in the America Free Zone (AFZ) in Heredia, Costa Rica, marking a significant milestone in its ongoing investment in Latin America. The company’s Costa Rica team has expanded to approximately 200 employees, reflecting the rapid growth and deep commitment to the country’s exceptional talent pool. Building on this momentum, Databricks plans to create 100 additional jobs in Costa Rica by the end of 2025, further strengthening its local operations and reinforcing Costa Rica’s strategic role in supporting customers and driving adoption of the Databricks Data Intelligence Platform across Latin America.

Since opening its Costa Rica office in 2023, Databricks has achieved over 150% growth in its LATAM business while supporting major regional customers such as BAC Latam, Nubank, Grupo Bimbo, iFood, Bineo and Kueski. As part of its broader strategy for Latin America, the company is expanding its São Paulo office and recently launched a new presence in Mexico City. These investments are fueled by rapidly growing enterprise demand for Databricks solutions across the region.

“Costa Rica plays a critical role in Databricks’ international expansion strategy,” said Rory Patterson, Chief of Staff to the CEO and VP of Corporate Operations at Databricks. “Our teams in Latin America are not only supporting global operations, they’re pioneering new automation and AI-based programs and processes that drive innovation across the company. This is a testament to the exceptional talent in Costa Rica and their ability to help us scale smarter, and not just faster.”

“Databricks has enabled us to realize our vision of a modern, intelligent, and flexible data and analytics strategy, strengthening our approach as a bank, personalizing our customers’ experience, and generating prosperity for the communities we serve,” said Rodrigo Chaverri, Corporate Director of Data & Analytics of BAC Latam.

The Minister of Foreign Trade, Manuel Tovar, commented, “Databricks’ expansion in Costa Rica strengthens the country’s position as a strategic tech hub for Latin America, supported by a highly skilled workforce, a reliable business environment, and robust digital infrastructure. With over 240 multinational companies in the sector and advanced capabilities in software, analytics, and artificial intelligence, Costa Rica offers a thriving ecosystem for digital solutions, nearshoring, and innovation. This new investment reaffirms the global tech sector’s confidence in our ability to lead complex processes from a secure, stable and competitive platform.”

“At Databricks, we believe in building our future with the best talent, and Costa Rica offers exactly that,” said Ariel Vargas, Director of International & LATAM Operations at Databricks. “Our new office will be a cornerstone for our Latin America operations, enabling us to better serve our customers and foster a culture of innovation and excellence. We look forward to welcoming new Bricksters to our growing team and collaborating with local partners and customers to drive innovation across the region.”

“The opening of Databricks’ new office in Costa Rica reinforces the country’s position as a strategic destination for knowledge-intensive services, which already account for 30% of our total exports. This expansion reflects the confidence that leading companies place in our business environment, legal certainty, and — above all — our highly skilled talent that drives digital transformation globally, every day,” said Laura López, CEO of the Trade & Investment Promotion Agency (PROCOMER).

Databricks’ investment in Costa Rica will support a wide range of roles, including Finance, HR, IT, Technical Support, Marketing, Operations and more. The company encourages interested professionals to explore opportunities and join its mission to democratize data and AI through the Data Intelligence Platform. For more information about career opportunities at Databricks Costa Rica, please visit the Databricks Careers page.

About Databricks

Databricks is the Data and AI company. More than 10,000 organizations worldwide — including Block, Comcast, Condé Nast, Rivian, Shell and over 60% of the Fortune 500 — rely on the Databricks Data Intelligence Platform to take control of their data and put it to work with AI. Databricks is headquartered in San Francisco, with offices around the globe, and was founded by the original creators of Lakehouse, Apache Spark™, Delta Lake and MLflow. To learn more, follow Databricks on LinkedIn, X and Facebook.

Contact: Press@databricks.com